CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology

CardieX's ATCOR subsidiary and Invaryant will work cohesively to conduct trials and improve patient outcomes IRVINE, Calif., Jan. 3, 2023 /PRNewswire/ -- CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient...

Click to view original post